References
- 1. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, et al. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J. 2004; 378: 919-8.
- 2. Guo J,Yan R, Xu G, Li W, Zheng C. Construction of the Vero cell culture system that can produce infectious HCV particles. Mol Biol. Rep 2007; 36: 111-20.
- 3. Jose LW, Gutierrez JA, EllIman WB, Stump DD, Keller TR, Rodriguez A, et al. Mutation Master: Profiles of substitutions inhepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA. 2002; 8: 557-71.
- 4. Ross RS, Viazov SO, Holtzer CD, Beyou A, Monnet A, Mazure C, et al. Genotyping of Hepatitis C Virus Isolates using CLIP Sequencing. J Clin Microbiol. 2000; 38: 3581-4.
- 5. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to inteterferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992; 16:293-9.10.1002/hep.1840160203
- 6. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C virus and response to interferon. Lancet. 1992; 339:1543.
- 7. Shah H.A, Jafri W, Malik I, Prescott L, Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol. 1997; 12: 758-61.
- 8. Szanto P, Grigorescu M, Dumitru I, Serban A. Steatosis in hepatitis C virus infection. Response to anti-viral therapy. J Gastrointestin Liver Dis. 2006; 15:117-24
- 9. Marzouk D, Sass J, Bakr I, Hosseiny ME, Hamid MA, Rekacewicz C, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007; 56:1105-10.
- 10. Asselah T, Boyer N, Guimont MC, Hatem DC, Tubach F , Nahon K, et al . Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut. 2003; 52:1638-43.
- 11. Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR. Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 Up-regulation during hepatitis C virus gene expression. Mol Pharmacol. 2006; 70: 627-36.10.1124/mol.106.023499
- 12. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol. 2007; 8: 8122-3.
- 13. Yoon EJ, Hu KQ. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci. 2006; 3:53-6.
- 14. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus-induced hepatocellular steatosis. Am J Gastroenterol. 2005; 100: 711-5.10.1111/j.1572-0241.2005.40898.x
- 15. Gupte P, Dudhade A, desai HG. Acquired apolipoprotein B deficiency with chronic hepatitis C virus infection. Indian J Gasrtroenterol. 2006; 25: 311-2.
- 16. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba KI, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997; 35: 201-7.
- 17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chemistry. 1972; 18: 499-502.
- 18. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a review of prevalence, genotypes and risk factors. World J Gastroenterology. 2010; in press.
- 19. Romero-Gomez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol. 2003; 98: 1135-41.
- 20. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004; 53: 406-12.
- 21. Afridi S, Naeem M, Hussain A, Kakar N, Babar ME, Ahmad J. Prevalence of hepatitis C virus (HCV) genotypes in Balochistan. Mol Biol Rep. 2009; 36: 1511-4.
- 22. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infectious Diseases. 2008; 8:69.
- 23. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus induced hepatocellular steatosis. Am J Gastroenterol. 2005; 100: 711-5.10.1111/j.1572-0241.2005.40898.x
- 24. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005; 43: 38-44.10.1016/j.jhep.2005.01.031
- 25. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y, et al: Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viralrelated steatosis. FASEB J. 2002, 16:185-94.10.1096/fj.01-0396com
- 26. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology. 2002, 292:198-210.
- 27. Kumar D,Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002; 36:1266-72.
- 28. Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, et al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology. 1999; 30:1064-76.
- 29. Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology. 2002; 35:937-46.10.1053/jhep.2002.32470
- 30. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002; 122:366-75.
- 31. Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, et al. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clin Gastroenterol Hepatol. 2007; 5: 388-93.
- 32. Hourioux C, Patient R, Morin A, Blanchard E, Moreau A, trassard S, et al. The genotype 3-specific hepatitis c virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut. 2007; 56: 1302-8.
- 33. Jackel-Cram C, Babiuk LA, Liu Q. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. J Hepatol. 2007; 46: 985-7.
- 34. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002; 122: 1649-57.
- 35. Guidi M, Muratori P, Granito A, Muratori L, Pappas G, Lenzi M, et al. Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin. Aliment Pharmacol Ther. 2005; 22:943-9.